Literature DB >> 16901300

Dermatological manifestations of Down's syndrome.

V Madan1, J Williams, J T Lear.   

Abstract

Down's syndrome (DS) is associated with rare dermatological disorders and increased frequency of some common dermatoses. Owing to advances in medical care and changes in attitude, the median age of death in this population has increased to 49 years, and the life expectancy of a 1-year-old person with DS today is more than 60 years and is likely to improve. With the increase in the number of individuals with DS in the population and an increased life span, dermatologists are more likely to encounter the wide spectrum of dermatological disorders that occurs in these patients. Furthermore, new reports of possible associations are frequent in the literature. The purpose of this article is to discuss the various dermatological conditions that affect DS individuals. A brief overview is given of the new information on genetics and the immunology of DS. We also discuss the molecular mechanisms of premature ageing, to which DS individuals are prone. We review the literature and discuss the known dermatological manifestations, concentrating on recent reports.

Entities:  

Mesh:

Year:  2006        PMID: 16901300     DOI: 10.1111/j.1365-2230.2006.02164.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  16 in total

1.  Health conditions associated with aging and end of life of adults with Down syndrome.

Authors:  Anna J Esbensen
Journal:  Int Rev Res Ment Retard       Date:  2010

2.  Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome.

Authors:  Xiao-Fei Kong; Lisa Worley; Darawan Rinchai; Vincent Bondet; Puthen Veettil Jithesh; Marie Goulet; Emilie Nonnotte; Anne Sophie Rebillat; Martine Conte; Clotilde Mircher; Nicolas Gürtler; Luyan Liu; Mélanie Migaud; Mohammed Elanbari; Tanwir Habib; Cindy S Ma; Jacinta Bustamante; Laurent Abel; Aimé Ravel; Stanislas Lyonnet; Arnold Munnich; Darragh Duffy; Damien Chaussabel; Jean-Laurent Casanova; Stuart G Tangye; Stéphanie Boisson-Dupuis; Anne Puel
Journal:  J Clin Immunol       Date:  2020-06-22       Impact factor: 8.317

3.  Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome.

Authors:  Katherine A Waugh; Paula Araya; Ahwan Pandey; Kimberly R Jordan; Keith P Smith; Ross E Granrath; Santosh Khanal; Eric T Butcher; Belinda Enriquez Estrada; Angela L Rachubinski; Jennifer A McWilliams; Ross Minter; Tiana Dimasi; Kelley L Colvin; Dmitry Baturin; Andrew T Pham; Matthew D Galbraith; Kyle W Bartsch; Michael E Yeager; Christopher C Porter; Kelly D Sullivan; Elena W Hsieh; Joaquin M Espinosa
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

Review 4.  Acrocyanosis: the Flying Dutchman.

Authors:  Andrew K Kurklinsky; Virginia M Miller; Thom W Rooke
Journal:  Vasc Med       Date:  2011-03-22       Impact factor: 3.239

5.  Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome.

Authors:  A Contestabile; T Fila; A Cappellini; R Bartesaghi; E Ciani
Journal:  Cell Prolif       Date:  2009-04       Impact factor: 6.831

6.  Down's syndrome and cardiac tamponade with pulmonary tuberculosis in adults.

Authors:  S K Verma; R Sodhi
Journal:  Indian J Hum Genet       Date:  2009-05

Review 7.  Clinical practice. The care of children with Down syndrome.

Authors:  Michel E Weijerman; J Peter de Winter
Journal:  Eur J Pediatr       Date:  2010-07-15       Impact factor: 3.183

8.  Reply: comment on 'Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican Inter-Institutional Group for the Identification of the Causes of Childhood Leukaemia (MIGICCL)'--a reality or myth or two viewpoints about the association between allergies and acute leukaemia in Down syndrome children.

Authors:  J C Núñez-Enríquez; A Fajardo-Gutiérrez; E P Buchán-Durán; E Jiménez-Hernández; J M Mejía-Aranguré
Journal:  Br J Cancer       Date:  2013-08-01       Impact factor: 7.640

9.  Elastosis perforans serpiginosa: a review of the literature and our own experience.

Authors:  Adriana Polańska; Monika Bowszyc-Dmochowska; Ryszard W Żaba; Zygmunt Adamski; Adam Reich; Aleksandra Dańczak-Pazdrowska
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

Review 10.  Down syndrome and type I interferon: not so simple.

Authors:  Louise Malle; Dusan Bogunovic
Journal:  Curr Opin Immunol       Date:  2021-06-23       Impact factor: 7.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.